Hainan Boao Lecheng Launches Precision Screening Center, Advancing Early Cancer Detection

Recently, the opening ceremony of the Meisai Precision Screening Center and the second anniversary celebration of Meisai Hospital were held in the Hainan Boao Lecheng International Medical Tourism Pilot Zone. Concurrently, the "318 Meisai International Health Festival" kicked off, bringing together medical experts, industry leaders, and cross-sector elites from around the world to explore new paths in medical technology innovation and health industry development.

The Meisai Precision Screening Center is a fully functional and highly innovative health screening center that integrates cutting-edge technologies such as early cancer screening, cardiovascular risk assessment, and AI-powered precise quantification. Its official operation will further enrich and improve the "prevention, treatment, care, and protection" industrial ecosystem, adding new momentum to the high-quality development of the Lecheng Pilot Zone.

The "318 Meisai International Health Festival," spanning 10 days from March 15 to 24, featured multiple thematic forums, including discussions on the Lizzy Cloud Health Strategy, AI in healthcare, and global medical integration trends and their empowerment of free trade ports.

Jia Ning, Party Secretary and Director of the Lecheng Administration, attended the launch event and stated that as the nation's only "medical special zone," Lecheng has always adhered to a people-centered development philosophy, leveraging policy benefits and aggregating high-quality medical resources to create a full life-cycle medical service covering prevention, screening, diagnosis, and rehabilitation. This meets the increasingly diversified health needs of the population. The opening of the Meisai Precision Screening Center will take a significant step forward in the field of "early screening and early diagnosis" and inject new vitality into Lecheng's precision medicine strategy. It is hoped that, through Lecheng's platform and policies, the center will fully leverage its advantages to provide international, precise, and personalized health management services for domestic and international patients, accelerating Lecheng's development into a world-class international medical tourism destination.

Brittany J. Schuchard, Senior Manager of the MCGC Project at Mayo Clinic, expressed her surprise at the environment, equipment, and service team of Meisai Hospital, noting that Mayo Clinic and Lizzy Care have maintained close cooperation centered on patient needs, achieving multiple collaborations in the healthcare field and establishing an important partnership.

Liu Xiangli, President of Lizzy Care and Hainan Meisai Hospital, stated that the Meisai Precision Screening Center represents a significant technological breakthrough for Meisai. In the future, it will fully utilize the preferential policies and resources of the Lecheng Pilot Zone, deepen cooperation with top domestic and international teams, and continue to build bridges for international medical collaboration. By introducing cutting-edge international technologies, equipment, and expert teams, the center will further develop specialized departments, delve deeper into precision medicine, and continuously explore innovations to enhance the level of precise and internationalized medical care. This will help Hainan's Free Trade Port become a global hub for precision medicine innovation and contribute to the implementation of the "Healthy China" strategy.